In NPC tissues, the expression level of FERMT1 was significantly correlated with the clinical stage of NPC patients, suggesting that FERMT1 might be involved in the progression of human NPC metastasis. This evidence concerns the gene FERMT1 and nasopharyngeal carcinoma.